COMPARISON OF TREATMENT RETENTION OF SECUKINUMAB AND TNF-INHIBITORS IN PSORIATIC ARTHRITIS. OBSERVATIONAL DATA FROM A NORDIC COLLABORATION.

被引：0

作者：

Lindstrom, U. ^{[1
]}

Glintborg, B. ^{[2
,3
]}

Di Giuseppe, D. ^{[4
]}

Jorgensen, T. Schjodt ^{[5
]}

Gudbjornsson, B. ^{[6
,7
]}

Gron, K. L. ^{[2
,3
]}

Provan, S. Aarrestad ^{[8
]}

Michelsen, B. ^{[8
]}

Hetland, M. L. ^{[2
,3
]}

Wallman, J. K. ^{[9
]}

Nordstrom, D. ^{[10
,11
]}

Trokovic, N. ^{[10
,11
]}

Love, T. ^{[6
]}

Krogh, N. Steen ^{[2
,3
]}

Askling, J. ^{[4
]}

Jacobsson, L. T. H. ^{[1
]}

Kristensen, L. E. ^{[5
]}

机构：

[1] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden

[2] COPECARE, Glostrup, Denmark

[3] DANBIO, Glostrup, Denmark

[4] Karolinska Inst, Stockholm, Sweden

[5] Frederiksberg & Bispebjerg Univ Hosp, Parker Inst, Copenhagen, Denmark

[6] Univ Iceland, Reykjavik, Iceland

[7] ICEBIO, Reykjavik, Iceland

[8] Diakonhjemmet Hosp, Oslo, Norway

[9] Lund Univ, Lund, Sweden

[10] Univ Helsinki, ROB FIN, Helsinki, Finland

[11] Helsinki Univ Hosp, Helsinki, Finland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.881

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0394

引用

下载

页码：427 / 428

页数：2

共 50 条

[31] EFFECTIVENESS AND RETENTION RATE OF SECUKINUMAB FOR PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN LORHEN REGISTRY
Favalli, E. G.
Marchesoni, A.
Balduzzi, S.
Montecucco, C.
Lomater, C.
Crepaldi, G.
Talamini, S.
Bazzani, C.
Fusaro, E.
Priora, M.
Iannello, A.
Paolazzi, G.
Caporali, R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 718 - 719
[32] Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register
Fagerli, Karen Minde
Kearsley-Fleet, Lianne
Watson, Kath D.
Packham, Jon
Symmons, Deborah P. M.
Hyrich, Kimme L.
RMD OPEN, 2018, 4 (01):
[33] Prediction of Low Disease Activity in Patients with Psoriatic Arthritis Treated with Secukinumab in Real World - Data from a German Observational Study
Vodencarevic, Asmir
Brandt-Juergens, Jan
Peterlik, Daniel
Gmeiner, Benjamin
Kiltz, Uta
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 953 - 954
[34] Effectiveness and Retention Rate of Secukinumab for Psoriatic Arthritis and Axial Spondyloarthritis: Real-life Data from the Italian LORHEN Registry
Favalli, Ennio Giulio
Marchesoni, Antonio
Balduzzi, Silvia
Montecucco, Carlomaurizio
Lomater, Claudia
Crepaldi, Gloria
Tamanini, Silvia
Bazzani, Chiara
Fusaro, Enrico
Priora, Marta
Ianniello, Aurora
Caporali, Roberto
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[35] LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY
Kiltz, U.
Sfikakis, P.
Gullick, N.
Katsimpri, P.
Kotrotsios, A.
Brandt-Juergens, J.
Lespessailles, E.
Maiden, N.
Gaffney, K.
Peterlik, D.
Schulz, B.
Pournara, E.
Jagiello, P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 846 - 847
[36] Co-medication with a conventional synthetic DMARD in patients with axial spondylarthritis is associated with improved retention of TNF inhibitors: results from the EuroSpA collaboration.
Nissen, M. J.
Delcoigne, B.
Di Giuseppe, D.
Jacobsson, L.
Fagerli, K.
Loft, Gitte A.
Ciurea, A.
Nordstrom, D.
Rotar, Z.
Iannone, F.
Santos, M. J.
Pombo-Suarez, M.
Gudbjornsson, B.
Mann, H.
Akkoc, N.
Codreanu, C.
van der Horst-Bruinsma, I
Michelsen, B.
Macfarlane, G.
Hetland, Lund M.
Tomsi, M.
Moller, B.
Avila-Ribeiro, P.
Sanchez-Piedra, C.
Relas, H.
Geirsson, A. J.
Nekvindova, L.
Cetin, Yildirim G.
Ionescu, R.
Askling, Y.
Glintborg, B.
Lindstrom, U.
SWISS MEDICAL WEEKLY, 2020, : 2S - 2S
[37] Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration (vol 56, 152081, 20222)
Ornbjerg, Lykke M.
Linde, Louise
Georgiadis, Stylianos
Rasmussen, Simon H.
Lindstrom, Ulf
Askling, Johan
Michelsen, Brigitte
Di Giuseppe, Daniela
Wallman, Johan K.
Pavelka, Karel
Zavada, Jakub
Nissen, Michael J.
Jones, Gareth T.
Relas, Heikki
Pirila, Laura
Tomsic, Matija
Rotar, Ziga
Geirsson, Arni Jon
Gudbjornsson, Bjorn
Kristianslund, Eirik K.
van der Horst-Bruinsma, Irene
Loft, Anne Gitte
Laas, Karin
Iannone, Florenzo
Corrado, Addolorata
Ciurea, Adrian
Santos, Maria J.
Santos, Helena
Codreanu, Catalin
Akkoc, Nurullah
Gunduz, Ozgul S.
Glintborg, Bente
Ostergaard, Mikkel
Hetland, Merete Lund
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
[38] Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
Manuel José Moreno-Ramos
Carlos Sanchez-Piedra
Olga Martínez-González
Carlos Rodríguez-Lozano
Carolina Pérez-Garcia
Mercedes Freire
Cristina Campos
Rafael Cáliz-Caliz
Jerusalem Calvo
Juan María Blanco-Madrigal
Ana Pérez-Gómez
María José Moreno-Martínez
Luis Linares
Fernando Sánchez-Alonso
Carlos Sastré
Isabel Castrejón
Rheumatology and Therapy, 2022, 9 : 1475 - 1476
[39] How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Psoriatic Arthritis? - Real World Data from a German Observational Study
Kiltz, Uta
Brandt-Juergens, Jan
Kaestner, Peter
Riechers, Elke
Peterlik, Daniel
Budden, Christina
Tony, Hans-Peter
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 781 - 783
[40] RETENTION OF TOCILIZUMAB AS MONOTHERAPY VERSUS TNF INHIBITORS WITH CONVENTIONAL SYNTHETIC DMARDS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF INHIBITORS: A STUDY FROM THE TOCERRA COLLABORATION
Lauper, K.
Nordstrom, D. C.
Pavelka, K.
Hernandez, V.
Santos, M. J.
Rotar, Z.
Iannone, F.
Codreanu, C.
Lukina, G.
Gale, S. L.
Sarsour, K.
Pethoe-Schramm, A.
Courvoisier, D. S.
Gabay, C.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 850 - 851

← 1 2 3 4 5 →